[Intravenous immunoglobulins in chronic idiopathic myositis].
Michels
H
H
Rheumaklinik für Kinder und Jugendliche, Gehfeldstr. 24, 82467 Garmisch-Partenkirchen, Germany. michels.hartmut@rummelsberger.net
Burmester
G-R
GR
Buttgereit
F
F
D000293:Adolescent; D000328:Adult; D002648:Child; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D000075202:Contraindications; D003882:Dermatomyositis / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects; D007074:Immunoglobulin G / Q000008:administration & dosage* / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D007262:Infusions, Intravenous; D008875:Middle Aged; D018979:Myositis, Inclusion Body / Q000188:drug therapy* / Q000276:immunology; D017285:Polymyositis / Q000188:drug therapy* / Q000276:immunology; D016896:Treatment Outcome
C021306:IgG, sulfonated; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents